Petroleo Brasileiro (PBR)
(Delayed Data from NYSE)
$15.02 USD
-0.21 (-1.38%)
Updated May 17, 2024 04:00 PM ET
After-Market: $15.01 -0.01 (-0.07%) 5:44 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
PBR 15.02 -0.21(-1.38%)
Will PBR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PBR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PBR
Investors Heavily Search Petroleo Brasileiro S.A.- Petrobras (PBR): Here is What You Need to Know
Company News For May 15, 2024
PBR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Petrobras (PBR) Q1 Earnings Lag on High Pre-Salt Lifting Costs
Will Petrobras (PBR) Report Q1 Earnings Beat on Output Gains?
Petrobras (PBR) Stock Moves 0.65%: What You Should Know
Other News for PBR
Smart Money Is Betting Big In PBR Options
Petrobras Q1 2024: Results Below Expectations And President Fired
Unveiling Petroleo Brasileiro SA Petrobras (PBR)'s Value: Is It Really Priced Right? A ...
CEO of Brazil’s oil and gas giant Petrobras steps down following dustup over dividends
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session